All Articles
1277 articles
CarsGibbs Phibian Goes from Truck to Boat in 10 Seconds
The Gibbs Phibian amphibious rescue truck can transition from road to water in under 10 seconds, carrying up to 15 people.
TechCanon EOS R6 Mark III Review: A Serious Hybrid Upgrade
Canon EOS R6 Mark III hands-on: a 32.5MP sensor, 7K 60p video, and improved AF make it a serious hybrid upgrade.
GamingMarathon free week launches June 2 with full gear reset
Bungie's Marathon free week (June 2-9) wipes all veteran gear for Season 2, adding a night map and Sentinel class.
TechAnthropic's Italian Enterprise Push: What It Means
Anthropic's Italian enterprise push, with a Milan office and deals with Generali, Pirelli and Enel, positions it as the Vatican-aligned challenger in Europe.
AIAnthropic's Milan Office Opens with Generali, Pirelli as Customers
Anthropic's Milan office opens with enterprise customers Generali, Pirelli, Enel, linking its launch to Pope Leo's AI encyclical.
PolicyIs Peter Thiel the Target of Pope Leo's Gandalf quote?
Pope Leo's Gandalf quote may target Peter Thiel, whose Tolkien firms and Antichrist warnings clash with Pope's vision.
SecurityIran's National Intranet Project: A Strategic Shift
Iran's national intranet project is exposed by a partial internet reconnection, highlighting a power struggle and digital sovereignty push.
HealthUS Blocks Ebola-Exposed Americans, Plans Kenya Quarantine
Ebola-Exposed Americans barred from US, moved to Kenya. CDC seeks volunteers for screening. Two doctors sent to Europe instead of home.
HealthION224 for Fatty Liver: What It Means for You
ION224, a new drug for MASH, blocks fat-producing enzyme DGAT2. In a trial, 60% of patients saw liver health improvements with no serious side effects. What now?
Gaming10 Horror Games Where You Play the Bad Guy
10 Horror Games Where You Play the Bad Guy: from a manipulated Jack in BioShock to the truly depraved Jimmy in Mouthwashing, here's what to know before you step into the monster's shoes.
ScienceBlastoid IVF Startups Reshape the Pregnancy Market
Blastoid IVF is moving from lab to market as startups Simbryo and dawn-bio develop tests and optimized media to cut IVF failure rates.
